METHOD FOR TREATING DEPRESSION AND MAJOR DEPRESSIVE DISORDER

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

15123072

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides methods for treating depression such as major depressive disorder (MDD) in an individual. The invention further provides methods for determining if an individual suffering from depression is likely to respond favorably or experience an enhanced treatment effect in response to treatment with vortioxetine. The present invention also provides methods for treating cognitive impairment in an individual, optionally wherein the individual also suffers from depression and/or MDD. The invention further provides methods for determining if an individual suffering from cognitive impairment is likely to respond favorably or experience an enhanced treatment effect in response to treatment with vortioxetine. The methods comprise determining the presence of polymorphisms in the collagen, type XXVI, alpha 1 (COL26A1) gene and/or the calcium channel, voltage-dependent, L type, alpha 1C subunit (CACNA1C) gene and/or the CUB and Sushi Multiple Domains 1 (CSMD1) gene and/or the Zinc Finger Protein 494 (ZSCAN4) gene and/or the Zinc Finger Protein 551 (ZNF551) gene and/or the dymeclin (DYM) gene and/or the LINC00348 gene and/or the FOXL2NB gene and/or intergenic regions in the individual.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
TAKEDA PHARMACEUTICAL COMPANY LIMITED1-1 DOSHOMACHI 4-CHOME CHUO-KU OSAKA-SHI OSAKA 541-0045

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Ffrench-Mullen, Jarlath Deerfield, US 3 0
Lai, Eric Deerfield, US 42 774

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation